When Columbia neurologist and scientist Neil Shneider speaks to his ALS patients who volunteer for experimental therapies, he's unwaveringly honest.

Huntington's disease is a genetic disorder that kills nerve cells in the brain, causing people to lose their cognitive and ...

In a study published in Nature Communications, researchers at the University of Wisconsin–Madison introduced a deep learning ...

This study proposes a new mechanism by which Chd1 senses and responds to DNA unwrapping via EDBL engagement to suppress ...

Developed by Sarepta Therapeutics, Elevidys is a one-time, intravenous treatment that uses adeno-associated virus (AAV) ...

Treatment with an experimental drug has shown significant improvements in young patients with a rare form of Amyotrophic ...

Researchers found that inhibiting GSK-3 led to less defects in the axonal transport process and less neuronal cell death, while inhibiting ERK1 led to more transport problems and more cell death.

The research team tested TS-DAR on a range of systems, including the translocation of a DNA motor protein (AlkD) along DNA. In each case, TS-DAR outperformed traditional methods in both accuracy ...

Using the gene scissors CRISPR and stem cells, researchers have managed to identify a common denominator for different gene mutations that all cause the neurological disease ALS. The research shows ...

King Charles and Queen Camilla marked 100 years since the dedication of Canada House, the home of the High Commission of ...

Searching for stability, the nanofibers bonded to amyloid-beta proteins, a key culprit implicated in Alzheimer’s disease. But ...